TheProfitWatch

RAPT - RAPT Therapeutics, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
27.61 -0.56 (-2.03%) 0.01 (0.04%) 0.0 (0.0%) 0.02 (0.06%) --- -0.56 (-2.03%) --- ---

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Market

Earnings & Ratios

Basic EPS:
-0.65
Diluted EPS:
-0.65
Basic P/E:
-41.6154
Diluted P/E:
-41.6154
RSI(14) 1m:
52.63
VWAP:
27.08
RVol:

Events

Period Kind Movement Occurred At

Related News